In utero intervention for severe congenital heart disease

Area of Science:

• Cardiology
• Fetal Medicine
• Developmental Biology

Background:

• Fetal cardiac therapy addresses congenital heart abnormalities during development.
• Current interventions are often palliative, with significant defects remaining at birth.
• Successful fetal interventions offer improved hemodynamics and reduced secondary damage, enhancing postnatal outcomes.

Purpose of the Study:

• To review the current state and future directions of fetal cardiac therapy.
• To highlight the potential benefits and limitations of various fetal cardiac interventions.
• To emphasize the need for evidence-based approaches, supported by randomized controlled trials.

Main Methods:

• Review of existing literature on fetal cardiac interventions.
• Discussion of specific procedures like fetal valvuloplasty and atrial septostomy.
• Exploration of novel techniques such as fetal pacemaker implantation and maternal hyperoxygenation.

Main Results:

• Fetal valvuloplasty aims for biventricular circulation in semilunar valve stenosis/atresia.
• Atrial foramen stenting can preserve pulmonary function in hypoplastic left heart syndrome.
• Emerging therapies include fetal pacemakers for heart block and hyperoxygenation for left heart growth.

Conclusions:

• Fetal cardiac therapy shows promise in improving hemodynamic function and postnatal outcomes.
• The long-term clinical benefits require further validation through rigorous research.
• Transitioning from pioneering to evidence-based practice is crucial for advancing fetal cardiac interventions.